Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2016

Jan 12, 2016

33819_dirs_2016-01-12_f98098b3-b88a-4708-a5e9-07484c9be537.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2016-01-08

Reporting Person: KOSHY GEORGE (chief accounting officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-01-08 Common Stock F 28457 $0.38 Disposed 357073 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 39648 Indirect

Footnotes

F1: This is recorded as a Code F disposition because the shares were used by the reporting person to pay a tax liability incurred by him from the delivery of shares incident to the vesting of restricted stock units.

F2: Includes (1) 50,000 restricted stock units, with 25,000 of this vesting on each of May 24, 2016 and May 24, 2017; (2) 10,000 restricted stock units vesting on January 27, 2016; (3) 130,000 restricted stock units, with 65,000 of these vesting on each of January 8, 2017 and January 8, 2018; and (4) 65,500 restricted stock units with performance based vesting.

F3: Shares held in 401(k) account, in accordance with issuer's employer-match policies.